Navigation Links
European Consumers Share a High Interest in Healthcare, but Hold Varied Views on Many Health Issues New TNS Healthcare Study Reveals Both Differences and Similarities in Health Views across Europe

NEW YORK, July 7 /PRNewswire/ -- More than 90% of consumers across the five major European markets--the UK, France, Italy, Germany and Spain-share an interest in health, according to a new study by TNS Healthcare, a Kantar Health Company. European woman are significantly more concerned with health than men, with 95% of females expressing interest in health issues vs. 89% of males. Age also makes a difference, with 55% of those older than 55 expressing an interest in health vs. just 44% of those between 18 and 24.

"The study indicates that, in all countries, most people take health for granted while they are young, particularly if they have no health issues," says Louise Tamblin, Practice Area Lead in Brand and Communications Research at TNS Healthcare UK. "Those who do suffer from any medical condition-even if it's minor-become significantly more interested in health than those who do not."

Europeans Have Many Areas of Commonality Europeans share the same views on many health issues. For example, the majority of consumers in all countries agree that they only go to the doctor when necessary. They also believe that they know when to visit a doctor vs. when to self medicate.

"Interestingly, doctors think differently about how well consumers judge whether to visit a physician or treat themselves," says Ginny Rose, Practice Area Lead in Patient Understanding, OTC and Consumer Health Research, TNS Healthcare UK. "For example, while 81% of consumers in the UK agree with the statement that they know when to go to the doctor and when to self medicate, more than 50% of doctors disagree."

Both consumers and doctors across the five countries surveyed share positive perceptions of pharmacists. There also was agreement on perceptions of OTC products, with UK respondents particularly positive about non-Rx treatments. For example, 77% of UK consumers and 85% of UK doctors believe that, for some health problems, the medicines consumers can buy are just as effective as those they would get from a doctor. In addition, 83% of UK consumers and 85% of UK doctors agree that it is important to be able to buy medicines without a prescription for minor ailments.

Findings Show Disagreement across Many Aspects of the Physician Relationship The TNS Healthcare survey reveals large differences among countries and between consumers and physicians in the same country on many aspect of the physician relationship. While 64% of consumers in the UK say that they would rather buy a medicine than visit a doctor, only 18% of that country's physicians agree. Spain comes out at the opposite end of the spectrum, with just 33% of consumers saying they would prefer to buy a medicine than visit a doctor--and only 10% of physicians agreeing. There also was broad disagreement on whether it is risky for people to treat minor ailments without seeing a doctor first. The percentage of consumers believing that it is very risky for people to self treat minor conditions ranged from 10% in the UK to 43% in Spain. On the physician side, respondents agreeing it is very risky ranged from just 4% in the UK to 49% in Italy. When asked whether they agree or disagree with the statement that doctors are too willing to prescribe treatments for minor ailments, doctors in most countries are harder on themselves than consumers are. For example, in the UK, 43% of doctors but only 26% of patients agree that doctors too often prescribe treatments for minor conditions. France and Spain show a similar pattern, with 40% of physicians but only about a quarter of consumers agreeing.

500 Physicians and 2500 Consumers Provide Insight TNS Healthcare's results are based on an on-line survey of 500 primary care physicians (100 per country) and 2,500 consumers 18 and older (500 per country) in the UK, France, Germany, Spain and Italy. The study was conducted in April 2009. About TNS Healthcare, a Kantar Health Company... TNS Healthcare, a Kantar Health company, provides market research consulting to the worldwide ethical and OTC pharmaceutical, biotech and medical device industries, as well as health-focused ad agencies, media and analysts. It offers globally consistent solutions and custom advisory services to support product introductions; brand, treatment and sales performance optimization; and physician and DTC promotional assessment. Informing decisions across the life cycle, TNS Healthcare offers action-ready insights for pre-launch landscaping, market and opportunity assessment, segmentation, positioning, message and campaign creation, pricing, forecasting, attitude and awareness measurement and post-launch tracking. It delivers information across stakeholders--including physicians, patients and consumers--to help companies anticipate and impact customers' behaviors. TNS Healthcare provides both qualitative and quantitative offerings, using traditional and on- line methodologies, combining worldwide reach with local expertise.

For more information, visit

SOURCE TNS Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New impact factor of European Urology underlines journals outstanding position
2. European Prices of 170 Best-Selling Drugs Averaged 40 Percent Less Than U.S. Prices in 2008
3. Frost & Sullivan Identifies Innovative and Cost-Effective Technology as Key Competitive Factor in European Medical Device Market
4. European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
5. Euro RSCG Life Acquires Medicom Group to Further Strengthen Its Global and European Medical Education Offering
6. Frost & Sullivan European Gastroenterology Technology Implementation of the Year Award Bestowed on Crospon
7. Simbionix Signs Agreement With the European Association for Endoscopic Surgery
8. The European Association for the Study of the Liver renews publishing partnership with Elsevier
9. Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market, States Frost & Sullivan
10. Prostate screening studies reviewed in European Urology July issue
11. Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... ... development solutions for drugs, biologics, consumer health and animal health products, today announced ... will lead a new, dedicated global team of drug development and technology experts. ...
(Date:10/12/2015)... Nashville, TN (PRWEB) , ... October 13, 2015 ... ... the recipients of its biannual Heroes in Recovery Awards at Foundations Recovery Network’s ... Foundations Recovery Network presented the one-of-a-kind awards to Noah Levine and Dean Dauphinais ...
(Date:10/12/2015)... ... October 13, 2015 , ... North American Tool Corporation has been named ... National Meeting in Rosemont, IL on October 4th. , Each year, ... excellence that customers have come to expect from members of IBC’s marketing group. ...
(Date:10/12/2015)... ... ... of the “Check-In and Win a Vacation to Hawaii” Facebook contest at Gold’s Gym ... didn’t believe I could win a free vacation simply by checking in on Facebook every ... and invest in my own health – and now I’m going to Hawaii.” , Thanks ...
(Date:10/12/2015)... ... , ... Amerec , a leader in the steam and sauna industry, ... be displaying custom sauna and steam room solutions at the ISPA Conference & Expo ... customers, SpaEquip is recognized for their ability to assist in the design and implementation ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... Minn. , Oct. 12, 2015 Device ... a need to help integrate these devices into existing ... of ergonomic healthcare mounting and mobility solutions, has launched ... lightest cart yet, for a wide array of laptops ... Cart SV10 was developed exclusively for Microsoft Surface and ...
(Date:10/12/2015)... , October 12, 2015 ... Forecast to grow at 7.2% CAGR, microscopy ... by rising focus on nanotechnology, technological advancements, ... research report available with ... . --> Complete report ...
(Date:10/12/2015)... England , Oct. 12, 2015 Indivior PLC ... the District of Delaware granted the ... Teva Pharmaceuticals, Abbreviated New Drug Application (ANDA) No. 205299 to ... SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) in ... --> Since August 2013, Indivior has received Paragraph ...
Breaking Medicine Technology: